LETTER TO THE EDITOR
Genomic information of children with malignant brain tumors for the prediction of length of hospitalization
Yichuan Liu, Hui-Qi Qu, Xiao Chang, Frank D Mentch, Haijun Qiu, Kenny Nguyen, Xiang Wang, Amir Hossein Saeidian, Deborah Watson, Joseph Glessner, Hakon Hakonarson
Cancer Communications 2023 43: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 8/9/2023 doi:10.1002/cac2.12475
ORIGINAL ARTICLE
MFSD2A potentiates gastric cancer response to anti-PD-1 immunotherapy by reprogramming the tumor microenvironment to activate T cell response
Bin Zhang, Chun-Mei Wang, Hao-Xiang Wu, Feng Wang, Yang-Yang Chai, Ye Hu, Bing-Jing Wang, Zhou Yu, Rong-Hua Xia, Rui-Hua Xu, Xue-Tao Cao
Cancer Communications 2023 43: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 8/4/2023 doi:10.1002/cac2.12476
ORIGINAL ARTICLE
Bin Zhang, Chun-Mei Wang, Hao-Xiang Wu, Feng Wang, Yang-Yang Chai, Ye Hu, Bing-Jing Wang, Zhou Yu, Rong-Hua Xia, Rui-Hua Xu, Xue-Tao Cao
Shujie Chen, Lina Fan, Yifeng Lin, Yadong Qi, Chaochao Xu, Qiwei Ge, Ying Zhang, Qiwen Wang, Dingjiacheng Jia, Lan Wang, Jianmin Si, Liangjing Wang
Cancer Communications 2023 43: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 8/2/2023 doi:10.1002/cac2.12469
LETTER TO THE EDITOR
Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)-T therapy has potential to reduce escape from single-target CAR-T with no more hematotoxicity
Zhenzhen Wang, Yang Lu, Yu Liu, Junli Mou, Xiaoyu Liu, Manling Chen, Ying Wang, Yingxi Xu, Qing Rao, Haiyan Xing, Kejing Tang, Zheng Tian, Bing Wang, Wei Qi, Min Wang, Shaowei Qiu, Dongsheng Xiong, Jianxiang Wang
Cancer Communications 2023 43: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 7/31/2023 doi:10.1002/cac2.12474
ORIGINAL ARTICLE
Worldwide trends in esophageal cancer survival, by sub-site, morphology, and sex: an analysis of 696,974 adults diagnosed in 60 countries during 2000-2014 (CONCORD-3)
Melissa Matz, Mikhail Valkov, Mario ?ekerija, Sabine Luttman, Adele Caldarella, Michel P Coleman, Claudia Allemani, the CONCORD Working Group
Cancer Communications 2023 43: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 7/24/2023 doi:10.1002/cac2.12457
RESEARCH HIGHLIGHT
Uncovering the IL-1β-PCAF-NNT axis: A new player in ferroptosis and tumor immune evasion
Qidong Li, Boyi Gan
Cancer Communications 2023 43: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 7/24/2023 doi:10.1002/cac2.12473
ORIGINAL ARTICLE
An HGF-dependent positive feedback loop between bladder cancer cells and fibroblasts mediates lymphangiogenesis and lymphatic metastasis
Yuting Li, Hanhao Zheng, Yuming Luo, Yan Lin, Mingjie An, Yao Kong, Yue Zhao, Yina Yin, Le Ai, Jian Huang, Changhao Chen
Cancer Communications 2023 43: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 7/22/2023 doi:10.1002/cac2.12470
LETTER TO THE EDITOR
Combined local therapy and CAR-GPC3 T-cell therapy in advanced hepatocellular carcinoma: a proof-of-concept treatment strategy
Yaoping Shi, Donghua Shi, Jiachang Chi, Dan Cui, Xiaoyin Tang, Yan Lin, Siying Wang, Zonghai Li, Haojie Jin, Bo Zhai
Cancer Communications 2023 43: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 7/21/2023 doi:10.1002/cac2.12472
ORIGINAL ARTICLE
Targeting histone deacetylase suppresses tumor growth through eliciting METTL14-modified m6A RNA methylation in ocular melanoma
Ai Zhuang, Xiang Gu, Tongxin Ge, Shaoyun Wang, Shengfang Ge, Peiwei Chai, Renbing Jia, Xianqun Fan
Cancer Communications 2023 43: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 7/19/2023 doi:10.1002/cac2.12471
RESEARCH HIGHLIGHT
The MonarchE trial: improving the clinical outcome in HR+/HER2 — early breast cancer: recent results and next steps
Fran?ois Bertucci, Pascal Finetti, Emilie Mamessier, Alexandre De Nonneville
Cancer Communications 2023 43: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 7/18/2023 doi:10.1002/cac2.12466
|
<< Page 1 of 62 >> |
